Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
11 hedge funds and large institutions have $4.28M invested in Yield10 Bioscience, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
15% less funds holding
Funds holding: 13 → 11 (-2)
24% less capital invested
Capital invested by funds: $5.66M → $4.28M (-$1.38M)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$21.7K |
| 2 |
BlackRock
New York
|
+$1.58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$300K |
| 2 |
CC
Cannell & Co
New York
|
-$78.2K |
| 3 |
Millennium Management
New York
|
-$29.5K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.54K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$395 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
AIGH Capital Management
Baltimore,
Maryland
| $1.68M | – | – | – |
|
|
CC
2
Cannell & Co
New York
| $862K | -$78.2K | -593 | -8% |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $576K | – | – | – |
|
|
WVP
4
Worth Venture Partners
Fort Lee,
New Jersey
| $392K | – | – | – |
|
|
5
Millennium Management
New York
| $249K | -$29.5K | -224 | -10% |
|
|
6
Geode Capital Management
Boston,
Massachusetts
| $213K | +$21.7K | +165 | +10% |
|
|
7
BlackRock
New York
| $209K | +$1.58K | +12 | +0.7% |
|
|
BC
8
Birchview Capital
Burlington,
Vermont
| $92K | -$264 | -2 | -0.3% |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $2K | -$5.54K | -42 | -69% |
|
|
RMC
10
Resources Management Corp
West Hartford,
Connecticut
| $1K | – | – | – |
|
|
11
Morgan Stanley
New York
| – | -$300K | -2,278 | Closed |
|
|
12
Bank of America
Charlotte,
North Carolina
| – | -$395 | -3 | Closed |
|
YTEN Hedge Fund Activity: Q4 2021 in Review
11 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q4 2021, worth a combined $4.28M — down 24% from $5.66M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of YTEN and 0 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 2 added.
The largest buyer was Geode Capital Management, adding an estimated $21.7K. The largest seller was Morgan Stanley, exiting entirely with an estimated $300K sold.
- 11 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q4 2021, down from 13 in Q3 2021.
- Funds reported $4.28M of Yield10 Bioscience, Inc. Common Stock stock for Q4 2021, down 24% quarter-over-quarter.
- 0 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q4 2021 and 2 closed out, a net change of -2 holders.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q4 2021 was Geode Capital Management, an estimated $21.7K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q4 2021 was Morgan Stanley, an estimated $300K sold.
Based on aggregated 13F filings for Q4 2021.